FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899991597> ?p ?o ?g. }

• W2899991597 endingPage "295" @default.
• W2899991597 startingPage "287" @default.
• W2899991597 abstract "The present study assessed the effectiveness of the combined administration of tranexamic acid (TXA) plus low‐dose epinephrine in primary total knee arthroplasty (TKA). We searched the following Chinese electronic databases: China National Knowledge Infrastructure and WanFang Data. We also searched the following English electronic databases: PubMed, Embase, Web of Science, and Central Register of Controlled Trials. To search for additional eligible studies, we also used Google's search engine. All randomized controlled trials (RCT) comparing TXA plus low‐dose epinephrine (Combined group) and TXA alone in TKA were systematically searched. The primary outcomes were total blood loss, hidden blood loss, the requirement for transfusion, maximum hemoglobin (Hb) drop, and deep venous thrombosis (DVT). Drainage volume, operation time, length of stay, hospital for special surgery (HSS) score, and range of motion (ROM) were considered as secondary outcomes. Subgroup analyses were performed to assess the benefits of using a tourniquet and the application routes of topical or intravenous TXA between the two groups. Statistical analysis was assessed using RevMan 5.3 software. Four independent RCT were included involving 426 patients, with 213 patients in the Combined group and 213 patients in the TXA alone group. In the Combined group there was significant reduction in total blood loss (MD, 204.70; 95% CI, −302.76 to −106.63; P < 0.0001), hidden blood loss (MD, 185.63; 95% CI, −227.56 to −143.71; P < 0.00001), drainage volume (MD, 93.49; 95% CI, −117.24 to −69.74; P < 0.00001), and maximum Hb drop (MD, 5.33, 95% CI, −6.75 to −3.91; P < 0.00001). No statistical differences were found postoperatively in terms of the requirement for transfusion (risk ratio, 0.52; 95% CI, 0.26–1.04; P = 0.06), operation time (MD, 0.85; 95% CI, −2.62 to 4.31; P = 0.63), length of stay (MD, −0.02; 95% CI, −0.52 to 0.47; P = 0.93), HSS score (MD, 0.78; 95% CI, −0.36 to 1.92; P = 0.18), and ROM (MD, 1.40; 95% CI, −1.01 to 3.81; P = 0.26), and not increasing the risk of DVT (risk ratio, 1.00; 95% CI, 0.33 to 3.02; P = 1.00) in the two groups. This meta‐analysis demonstrated that the administration of tranexamic acid plus low‐dose epinephrine is a safe and efficacious treatment to reduce total blood loss, hidden blood loss, drainage volume, and maximum Hb drop in primary TKA, without increasing the risk of DVT in primary THA." @default.
• W2899991597 created "2018-11-16" @default.
• W2899991597 creator A5000515886 @default.
• W2899991597 creator A5005882410 @default.
• W2899991597 creator A5035395410 @default.
• W2899991597 creator A5050510302 @default.
• W2899991597 creator A5067326077 @default.
• W2899991597 creator A5086639126 @default.
• W2899991597 date "2018-11-01" @default.
• W2899991597 modified "2023-10-09" @default.
• W2899991597 title "Tranexamic Acid Plus Low-dose Epinephrine Reduces Blood Loss in Total Knee Arthroplasty: A Systematic Review and Meta-analysis" @default.
• W2899991597 cites W1768071396 @default.
• W2899991597 cites W1966334324 @default.
• W2899991597 cites W1971048754 @default.
• W2899991597 cites W2021406328 @default.
• W2899991597 cites W2047227791 @default.
• W2899991597 cites W2050118439 @default.
• W2899991597 cites W2050185674 @default.
• W2899991597 cites W2051239218 @default.
• W2899991597 cites W2071710501 @default.
• W2899991597 cites W2098923148 @default.
• W2899991597 cites W2128863777 @default.
• W2899991597 cites W2166865523 @default.
• W2899991597 cites W2169817953 @default.
• W2899991597 cites W2171200723 @default.
• W2899991597 cites W2173433192 @default.
• W2899991597 cites W2263061095 @default.
• W2899991597 cites W2276370991 @default.
• W2899991597 cites W2333175638 @default.
• W2899991597 cites W2402544895 @default.
• W2899991597 cites W2550764496 @default.
• W2899991597 cites W2564609968 @default.
• W2899991597 cites W2588681363 @default.
• W2899991597 cites W2592526888 @default.
• W2899991597 cites W2593186101 @default.
• W2899991597 cites W2609727611 @default.
• W2899991597 cites W2703862921 @default.
• W2899991597 cites W2765982410 @default.
• W2899991597 cites W2794229073 @default.
• W2899991597 cites W4231899502 @default.
• W2899991597 cites W611189448 @default.
• W2899991597 doi "https://doi.org/10.1111/os.12404" @default.
• W2899991597 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6594507" @default.
• W2899991597 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30406972" @default.
• W2899991597 hasPublicationYear "2018" @default.
• W2899991597 type Work @default.
• W2899991597 sameAs 2899991597 @default.
• W2899991597 citedByCount "7" @default.
• W2899991597 countsByYear W28999915972020 @default.
• W2899991597 countsByYear W28999915972021 @default.
• W2899991597 countsByYear W28999915972022 @default.
• W2899991597 crossrefType "journal-article" @default.
• W2899991597 hasAuthorship W2899991597A5000515886 @default.
• W2899991597 hasAuthorship W2899991597A5005882410 @default.
• W2899991597 hasAuthorship W2899991597A5035395410 @default.
• W2899991597 hasAuthorship W2899991597A5050510302 @default.
• W2899991597 hasAuthorship W2899991597A5067326077 @default.
• W2899991597 hasAuthorship W2899991597A5086639126 @default.
• W2899991597 hasBestOaLocation W28999915971 @default.
• W2899991597 hasConcept C126322002 @default.
• W2899991597 hasConcept C141071460 @default.
• W2899991597 hasConcept C168563851 @default.
• W2899991597 hasConcept C187960798 @default.
• W2899991597 hasConcept C2775859304 @default.
• W2899991597 hasConcept C2778959117 @default.
• W2899991597 hasConcept C2779400597 @default.
• W2899991597 hasConcept C2779637338 @default.
• W2899991597 hasConcept C2780011451 @default.
• W2899991597 hasConcept C2780014101 @default.
• W2899991597 hasConcept C2780868729 @default.
• W2899991597 hasConcept C2991743468 @default.
• W2899991597 hasConcept C42219234 @default.
• W2899991597 hasConcept C71924100 @default.
• W2899991597 hasConcept C95190672 @default.
• W2899991597 hasConceptScore W2899991597C126322002 @default.
• W2899991597 hasConceptScore W2899991597C141071460 @default.
• W2899991597 hasConceptScore W2899991597C168563851 @default.
• W2899991597 hasConceptScore W2899991597C187960798 @default.
• W2899991597 hasConceptScore W2899991597C2775859304 @default.
• W2899991597 hasConceptScore W2899991597C2778959117 @default.
• W2899991597 hasConceptScore W2899991597C2779400597 @default.
• W2899991597 hasConceptScore W2899991597C2779637338 @default.
• W2899991597 hasConceptScore W2899991597C2780011451 @default.
• W2899991597 hasConceptScore W2899991597C2780014101 @default.
• W2899991597 hasConceptScore W2899991597C2780868729 @default.
• W2899991597 hasConceptScore W2899991597C2991743468 @default.
• W2899991597 hasConceptScore W2899991597C42219234 @default.
• W2899991597 hasConceptScore W2899991597C71924100 @default.
• W2899991597 hasConceptScore W2899991597C95190672 @default.
• W2899991597 hasFunder F4320322922 @default.
• W2899991597 hasIssue "4" @default.
• W2899991597 hasLocation W28999915971 @default.
• W2899991597 hasLocation W28999915972 @default.
• W2899991597 hasLocation W28999915973 @default.
• W2899991597 hasLocation W28999915974 @default.
• W2899991597 hasOpenAccess W2899991597 @default.
• W2899991597 hasPrimaryLocation W28999915971 @default.
• W2899991597 hasRelatedWork W1980425693 @default.

• next